Literature DB >> 6417218

The dissociation of the exaggerated prolactin and thyrotropin responses in seminiferous tubule failure following the administration of a double-pulse of thyrotropin-releasing hormone.

I M Spitz, B Levitt, E Zylber-Haran, M Haas, Y Livshin.   

Abstract

PRL and TSH secretion has been evaluated in 11 patients with seminiferous tubule failure and 9 controls. When compared to the controls, the patients had increased basal FSH, TSH and PRL levels. However, LH, E2, T and thyroid hormone levels were similar to the controls. Both groups were given two pulses of TRH (200 micrograms) at 30 min intervals. Following the initial pulse of TRH, the patients demonstrated exaggerated TSH and PRL responses. The administration of a second pulse of TRH led to a further increment of TSH secretion in the patients. There was, however, no PRL response to the second TRH pulse in either patients or controls although mean PRL levels remained significantly greater in the patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417218     DOI: 10.1007/BF03347589

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  11 in total

1.  The prolactin response to repeated intravenous stimuli.

Authors:  I M Spitz; B Gonen; R Luboshitzky; E Rosen; O Shemesh
Journal:  Horm Metab Res       Date:  1979-04       Impact factor: 2.936

2.  Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination.

Authors:  C H Mortimer; G M Besser; A S McNeilly; W M Tunbridge; A Gomez-Pan; R Hall
Journal:  Clin Endocrinol (Oxf)       Date:  1973-10       Impact factor: 3.478

3.  Prolactin response to thyrotropin releasing hormone in normal subjects.

Authors:  L S Jacobs; P J Snyder; R D Utiger; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1973-06       Impact factor: 5.958

4.  Unimpaired prolactin response to teat stimulation during diminished response to continuous infusion of TRH.

Authors:  V Reinhardt; D Schams
Journal:  Horm Metab Res       Date:  1975-07       Impact factor: 2.936

5.  Clomiphene attenuates the exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide occurring in primary testicular failure.

Authors:  I M Spitz; Y Halperin; S Shilo; D LeRoith; E Zylber-Haran; Y Livshin; N Laufer; J Schenker
Journal:  J Clin Endocrinol Metab       Date:  1981-02       Impact factor: 5.958

6.  Effect of acute increases in serum triiodothyronine on TSH and prolactin responses to TRH, and estimates of pituitary stores of TSH and prolactin in normal subjects and in patients with primary hypothyroidism.

Authors:  L Wartofsky; R C Dimond; G L Noel; A G Frantz; J M Earll
Journal:  J Clin Endocrinol Metab       Date:  1976-03       Impact factor: 5.958

7.  Prolactin response to metoclopramide and chlorpromazine in primary testicular failure and isolated gonadotrophin deficiency.

Authors:  I M Spitz; Y Halperin; E Zylber-Haran; S Shilo; D Leroith; Y Liel; J Livshin; N Laufer; J Schenker
Journal:  Clin Endocrinol (Oxf)       Date:  1981-04       Impact factor: 3.478

8.  The TSH response to TRH is exaggerated in primary testicular failure and normal in the male castrate.

Authors:  D LeRoith; Y Liel; J Sack; Y Livshin; N Laufer; J Schenker; I M Spitz
Journal:  Acta Endocrinol (Copenh)       Date:  1981-05

9.  Dissociation between sleep-related and TRH-induced prolactin secretion in seminiferous tubule failure.

Authors:  I M Spitz; P Lavie; N Calderon; C R Gordon; A Oksenberg; M Ron; N Laufer; Y Livshin; J Schenker
Journal:  Metabolism       Date:  1982-01       Impact factor: 8.694

10.  Exaggerated prolactin response to thyrotropin-releasing hormone and metoclopramide in primary testicular failure.

Authors:  I M Spitz; D LeRoith; Y Livshin; E Zylber-Haran; S Trestian; N Laufer; M Ron; Z Palti; J Schenker
Journal:  Fertil Steril       Date:  1980-12       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.